Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT02003573 · TERMINATED
Trial details
- NCT number
- NCT02003573
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-29
- Primary completion
- 2015-01-06
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.